ストックスクリーナーアプリを入手
0.9125
1.33%
-0.0123
前日終値:
$0.9248
開ける：
$0.925
24時間の取引高:
25,135
Relative Volume:
0.09
時価総額：
$29.68M
収益：
$950.10K
当期純損益:
$-16.69M
株価収益率:
-1.0994
EPS:
-0.83
ネットキャッシュフロー:
$-15.16M
1週間 パフォーマンス:
-1.81%
1か月 パフォーマンス:
+2.61%
6か月 パフォーマンス:
-13.10%
1年 パフォーマンス:
-19.96%
1日の値動き範囲:
$0.91
$0.925
1週間の範囲:
$0.90
$0.9895
52週間の値動き範囲:
$0.693
$1.80
Femasys Inc Stock (FEMY) Company Profile
FEMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.9125 | 30.23M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
518.02 | 191.65B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
174.84 | 49.57B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.72 | 42.93B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
255.33 | 37.60B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
226.50 | 15.91B | 2.90B | 467.20M | 306.90M | 6.37 |
Femasys Inc (FEMY) 最新ニュース
XENE CEO Named Interim CFO After Sherry Aulin Resigns | FEMY SEC FilingForm 8-K - Stock Titan
Major Breakthrough: Australia and NZ Approve Femasys Revolutionary First-Line Infertility Solutions - Stock Titan
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic - The Manila Times
Femasys Achieves Australian and New Zealand Regulatory - GlobeNewswire
Femasys Enters Purchase Agreement with Alumni Capital - TipRanks
Femasys stock rises as FemBloc gets CE Mark for permanent birth control - Investing.com Canada
Femasys Receives European Approval for FemBloc Non-Surgical Permanent Birth Control - Femtech Insider
Femasys appoints Kelley Nicholas as chief commercial officer - Investing.com
Femasys appoints Kelley Nicholas as chief commercial officer By Investing.com - Investing.com Canada
Femasys Appoints Kelley Nicholas as Chief Commercial Officer - TipRanks
Femasys (FEMY) Appoints Kelley Nicholas as Chief Commercial Officer | FEMY Stock News - GuruFocus
Femasys appoints Nicholas as CCO - TipRanks
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewswire
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN
40,968 Shares in Femasys Inc. (NASDAQ:FEMY) Acquired by Citadel Advisors LLC - Defense World
Femasys (NASDAQ:FEMY) Receives “Buy” Rating from HC Wainwright - Defense World
A Closer Look at Femasys Inc (FEMY) Stock Gains - investchronicle.com
The Analyst Verdict: Femasys In The Eyes Of 6 Experts - Benzinga
Femasys (FEMY): Buy Rating Reiterated by HC Wainwright & Co. | FEMY Stock News - GuruFocus
Femasys: Strategic Partnerships and Revenue Growth Drive Buy Rating with $12 Price Target - TipRanks
Femasys Announces Partnership with Carolinas Fertility - GlobeNewswire
Femasys announces partnership with Carolinas Fertility Institute - TipRanks
Femasys (FEMY) Partners with Carolinas Fertility Institute for FemaSeed Distribution | FEMY Stock News - GuruFocus
Major Fertility Breakthrough: Leading US Clinic Network Adopts Femasys FemaSeed as IVF Alternative - Stock Titan
Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations - The Manila Times
Jane Street Group LLC Acquires New Stake in Femasys Inc. (NASDAQ:FEMY) - Defense World
Femasys Executives Make Bold Moves with Major Stock Purchases! - TipRanks
Northern Trust Corp Purchases 37,675 Shares of Femasys Inc. (NASDAQ:FEMY) - Defense World
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up - Asianet Newsable
Femasys Announces Public Offering and Private Placement - TipRanks
Femasys announces pricing of underwritten public offering and concurrent private placement with gross proceeds of $4.5M - MSN
Femasys sets pricing for stock offering and private placement By Investing.com - Investing.com South Africa
Femasys stock hits 52-week low at $0.82 amid market challenges By Investing.com - Investing.com South Africa
FEMY Announces Public Offering and Private Placement Pricing | F - GuruFocus
Femasys stock hits 52-week low at $0.82 amid market challenges - Investing.com Canada
Femasys Announces $4.5 Mln Offering Through Public Sale And Private Placement Of Shares - Nasdaq
Femasys prices 3.6M shares at 85c in underwritten public offering - TipRanks
Femasys (FEMY) Announces Stock Offering to Raise $4.5 Million - GuruFocus
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up By Stocktwits - Investing.com India
FEMY Announces Public Offering and Private Placement Pricing | FEMY Stock News - GuruFocus
Femasys sets pricing for stock offering and private placement - Investing.com
Femasys Announces Pricing Of Underwritten Public Offering And Concurrent Private Placement With Gross Proceeds Of $4.5 Million - marketscreener.com
Femasys Announces Pricing of Underwritten Public Offering - GlobeNewswire
Women's Health Innovator Femasys Secures $4.5M Strategic Financing to Accelerate Commercial Growth - Stock Titan
Femasys plans stock offering and private placement By Investing.com - Investing.com South Africa
Femasys announces common stock offering, no amount given - TipRanks
Femasys Plans Public Offering, Concurrent Private Placement - MarketScreener
Femasys plans stock offering and private placement - Investing.com
FEMY Announces Public Offering to Fuel Expansion and Development | FEMY Stock News - GuruFocus
Shootin' the Bull about growing everything bigger - The Globe and Mail
Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement - The Manila Times
Femasys Inc (FEMY) 財務データ
収益
当期純利益
現金流量
EPS
0.20%
0.87%
大文字化:
|
ボリューム (24 時間):